Cancer clinical trials: Welcome to the DERMA study site!
DERMA is a large Phase III clinical study in patients with melanoma skin cancer. It will evaluate a potential new cancer treatment called ASCI* (Antigen-Specific Cancer Immunotherapeutics) in melanoma patients with stage 3B or 3C melanoma which has spread macroscopically to the lymph node, and who have had an operation to remove their tumor. This site is for cancer patients and their families who would like to find out about the study.
The results of early studies of ASCI* in people led to the setting up of DERMA. This study will investigate if the ASCI is safe for patients and how well it works. DERMA is currently recruiting patients to take part in the study.
Clinical studies (also called clinical trials) are carried out in volunteer patients, and follow strict rules. This site tells you about DERMA and cancer clinical trials. You can:
- Find out more about clinical studies – what they are and how they work
- Find out about DERMA – what it involves, and whether you are eligible to participate
- Find a DERMA study center near you
If you are interested in participating in DERMA, follow these 3 steps:
- Find out what DERMA involves
- Check if you are suitable for this study.
- Find a DERMA study center close to where you live and contact that hospital for a first discussion on the study, and your potential participation in it.
It is a good idea to talk about the study with your own doctor. He or she knows your individual case and will be able to help you decide whether you want to participate.
Thank you for your interest in the DERMA study.
